Association Between the Brain Excitability and Postoperative Delirium in Patients Undergoing Heart Valve Replacement Surgery With Cardiopulmonary Bypass

Association Between the Brain Excitability and Postoperative Delirium in Patients Undergoing Heart Valve Replacement Surgery With Cardiopulmonary Bypass: a Prospective Cohort Study

The purpose of this study is to explorethe brain excitability in patients undergoing heart valve replacement surgery with cardiopulmonary bypass and the correlation with postoperative delirium

Study Overview

Detailed Description

Delirium is the most common surgical patients postoperative complications of brain dysfunction. Delirium is a kind of consciousness attention and cognitive function changes of acute brain dysfunction, with volatility and reversibility of postoperative delirium (POD), increased hospital costs and length of hospital stay and mortality rate, and can lower the quality of life, lead to long-term postoperative cognitive dysfunction and dementia. The incidence of postoperative cognitive dysfunction in patients undergoing cardiac valve replacement under cardiopulmonary bypass (CPB) can be as high as 44-53%. However, since the specific mechanism of POD is still not clear, there is still a lack of effective prevention and treatment measures. Therefore, early detection and identification are helpful for the early treatment of POD.When brain injury occurs, the levels of excitatory neurotransmitters (glutamate and aspartate) will rise in a short period of time, and the high concentration of glutamate causes excessive intracellular calcium flow, causing cellular calcium overload, and generating excitatory cytotoxic effects. And abnormal electroencephalogram (EEG) is a kind of due to brain excitability/inhibitory amino acid imbalance caused by brain excitability increased result in abnormal discharge mode, can affect cognitive awareness and activities. Increased brain excitability is harmful to the potential, should avoid to happen. At present, the relationship between brain excitability and POD is still in exploring. Therefore, it is important to clarify the correlation between brain excitability and POD in patients undergoing cardiac valve replacement under CPB for improving the pathogenesis of POD.

Study Type

Observational

Enrollment (Anticipated)

90

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ningxia
      • Yinchuan, Ningxia, China, 750004
        • Recruiting
        • General Hospital of Ningxia Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • ADULT
  • OLDER_ADULT
  • CHILD

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The patients undergoing heart valve replacement surgery with cardiopulmonary bypass

Description

Inclusion Criteria:

  1. ASA Ⅱ - Ⅲ;
  2. No cognitive impairment was assessed one day before surgery;
  3. Patients undergoing elective heart valve replacement under CPB and signed informed consent.

Exclusion Criteria:

  1. Non-CPB surgery, macrovascular surgery, heart transplantation, correction of congenital heart disease;
  2. Stroke, schizophrenia, depression, Parkinson's disease, epilepsy or dementia;
  3. Inability to communicate with language impairment or major hearing or visual impairment;
  4. Liver function child-pugh Grade C, severe liver dysfunction;
  5. Severe renal insufficiency requires preoperative renal replacement therapy;
  6. A past history of intraoperative knowledge.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The incidence of delirium after cardiac surgery
Time Frame: The first day after surgery
Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).
The first day after surgery
The incidence of delirium after cardiac surgery
Time Frame: The second day after surgery
Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).
The second day after surgery
The incidence of delirium after cardiac surgery
Time Frame: The third day after surgery
Postoperative evaluation delirium occurrence use the The Confusion Assessment Method(CAM) or The Confusion Assessment Method-intensive care unit(CAM-ICU).
The third day after surgery
Abnormal EEG during surgery
Time Frame: Complete EEG information from entry to exit of the operating room
The EEG was collected by Masimo instrument, and the EEG was recognized by the neuroelectrophysiologist, to identify whether the EEG of the patient was epileptic discharge and burst suppression during anesthesia
Complete EEG information from entry to exit of the operating room
Plasma excitatory amino acid levels
Time Frame: Before the operation after entering the operating room (baseline)
Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.
Before the operation after entering the operating room (baseline)
Plasma excitatory amino acid levels
Time Frame: Immediately after surgery
Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.
Immediately after surgery
Plasma excitatory amino acid levels
Time Frame: 24 hours after surgery
Venous blood 5ml was collected and centrifuged (3500r/min,10min),sera were separated and put into -80 deep temperature refrigerator for testing plasma excitatory amino acid levels.
24 hours after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

July 1, 2020

Primary Completion (ANTICIPATED)

December 1, 2021

Study Completion (ANTICIPATED)

December 1, 2021

Study Registration Dates

First Submitted

July 27, 2021

First Submitted That Met QC Criteria

August 4, 2021

First Posted (ACTUAL)

August 12, 2021

Study Record Updates

Last Update Posted (ACTUAL)

August 12, 2021

Last Update Submitted That Met QC Criteria

August 4, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Delirium

Subscribe